“Ukatamanga weka utamangisa, tikatamanga awili, tifikapatali" - When you run alone, you run fast. When you run together, you run fast - Zambian Proverb

UNZA-UCLMS

Research and Training Programme

Publications 2019

Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention.

Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, Zumla A.

Infect Dis Clin North Am. 2019 Apr 10. pii: S0891-5520(19)30017-0. doi: 10.1016/j.idc.2019.03.001. [Epub ahead of print] Review.


Editorial: Toward improving the diagnosis, treatment and prevention of community acquired and nosocomial respiratory tract infections.

Niederman MS, Zumla A.

Curr Opin Pulm Med. 2019 May;25(3):217-219. doi: 10.1097/MCP.0000000000000577. No abstract available.


Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease.

Tembo J, Simulundu E, Changula K, Handley D, Gilbert M, Chilufya M, Asogun D, Ansumana R, Kapata N, Ntoumi F, Ippolito G, Zumla A, Bates M.

Expert Rev Mol Diagn. 2019 Apr;19(4):325-340. doi: 10.1080/14737159.2019.1595592. Epub 2019 Apr 5.


After the UNGA High-Level Meeting on Tuberculosis-what next and how?

Sahu S, Ditiu L, Zumla A.

Lancet Glob Health. 2019 May;7(5):e558-e560. doi: 10.1016/S2214-109X(19)30068-3. Epub 2019 Mar 12. No abstract available.


Revolutionary new treatment regimens for multidrug-resistant tuberculosis.

McHugh TD, Honeyborne I, Lipman M, Zumla A.

Lancet Infect Dis. 2019 Mar;19(3):233-234. doi: 10.1016/S1473-3099(19)30060-X. No abstract available.


Latent tuberculosis infection: diagnostic tests and when to treat.

Petersen E, Chakaya J, Jawad FM, Ippolito G, Zumla A.

Lancet Infect Dis. 2019 Mar;19(3):231-233. doi: 10.1016/S1473-3099(19)30059-3. No abstract available.


Isoniazid preventive therapy for children in sub-Saharan Africa.

Meremikwu M, Zumla A.

Lancet Respir Med. 2019 Mar;7(3):197-199. doi: 10.1016/S2213-2600(19)30037-2. No abstract available.


Towards optimal treatment for latent Mycobacterium tuberculosis infection.

Abubakar I, Chakaya J, Maeurer M, Zumla A.

Lancet Respir Med. 2019 Mar;7(3):195-197. doi: 10.1016/S2213-2600(19)30036-0. No abstract available.


Latent TB Infection (LTBI) - Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground.

Rao M, Ippolito G, Mfinanga S, Ntoumi F, Yeboah-Manu D, Vilaplana C, Zumla A, Maeurer M.

Int J Infect Dis. 2019 Mar;80S:S58-S61. doi: 10.1016/j.ijid.2019.02.035. Epub 2019 Feb 26.


World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme Series.

Petersen E, Rao M, Ippolito G, Gualano G, Chakaya J, Ntoumi F, Moore D, Allen R, Gaskell K, Öhd JN, Hergens MP, Krishnamoorthy S, Ugarte-Gil C, Kirwan DE, Honeyborne I, McHugh TD, Köser CU, Kranzer K, Tiberi S, Migliori GB, Mao Q, Yang Y, Oliveira SP, Cardoso RF, Detjen A, Marais B, de Gijsel D, von Reyn CF, Goscé L, Abubakar I, Maeurer M, Zumla A.

Int J Infect Dis. 2019 Mar;80S:S1-S5. doi: 10.1016/j.ijid.2019.02.024. Epub 2019 Feb 23. No abstract available.


The changing treatment landscape for MDR/XDR-TB - Can current clinical trials revolutionise and inform a brave new world?

Honeyborne I, Lipman M, Zumla A, McHugh TD.

Int J Infect Dis. 2019 Mar;80S:S23-S28. doi: 10.1016/j.ijid.2019.02.006. Epub 2019 Feb 15. No abstract available.


Latent tuberculosis infection and renal transplantation - Diagnosis and management.

Krishnamoorthy S, Kumaresan N, Zumla A.

Int J Infect Dis. 2019 Mar;80S:S73-S76. doi: 10.1016/j.ijid.2019.01.049. Epub 2019 Feb 6.


Tuberculin skin test - Outdated or still useful for Latent TB infection screening?

Gualano G, Mencarini P, Lauria FN, Palmieri F, Mfinanga S, Mwaba P, Chakaya J, Zumla A, Ippolito G.

Int J Infect Dis. 2019 Mar;80S:S20-S22. doi: 10.1016/j.ijid.2019.01.048. Epub 2019 Feb 6. Review.


Transmission and prevention of acute viral respiratory tract infections in hospitals.

Wilson P, Zumla A.

Curr Opin Pulm Med. 2019 May;25(3):220-224. doi: 10.1097/MCP.0000000000000566.


Improving treatment outcomes for MDR-TB - Novel host-directed therapies and personalised medicine of the future.

Rao M, Ippolito G, Mfinanga S, Ntoumi F, Yeboah-Manu D, Vilaplana C, Zumla A, Maeurer M.

Int J Infect Dis. 2019 Mar;80S:S62-S67. doi: 10.1016/j.ijid.2019.01.039. Epub 2019 Jan 24.


Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era.

Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, Asogun D, Mukonka V, Lule SA, Bates M, Honeyborne I, Mfinanga S, Mwaba P, Dar O, Vairo F, Mukhtar M, Kock R, McHugh TD, Ippolito G, Zumla A.

Int J Infect Dis. 2019 Jan;78:78-84. doi: 10.1016/j.ijid.2018.11.008. Epub 2018 Nov 16. Review.




For a complete list of our high profile Journal Theme Series from 1999-2018, click here

Publications Summary 1982-2019
Int J infect Dis
62
Lancet  Infect Dis Infect Dis
51
Lancet Infect Dis
52
Curr Opin Pulm Med
34
J Infect Dis
20
Clin Infect Dis
17
Lancet Resp Med
19
PLoS One
16
Eur Respir J
15
Trop Med Int Health
15
Int J Tuberc Lung Dis
13
Am J Respir Crit Care Med
10
N Eng J Med
8
BMJ
8
J Infect
7
S Afr Med J
7
Infect Dis Clin North Am
7
Nature Rev. Drug. Dis
5
BMC Med
8
J Clin Microbiol  
5
Postgrad Med J
5
Clin Microbiol Infect
5
AIDS
4
Clin Chest Med 
J Antimicrob Chemotherapy
4
J R Soc Med 
Thorax
4
Trans R Soc Trop Med Hyg
4
Tuberculosis (Edinb) 
Other
144
 TOTAL
561